// Definition
A broad patent filed by GW Pharmaceuticals claiming all cannabinoids for use in neuroprotection, effectively attempting to monopolize an entire therapeutic category of cannabis-based treatments.
// From the Episode
Discussed with concern by the panel. Mark Scialdone noted that GW essentially patented all cannabinoids for neuroprotective use, raising alarm about corporate control over cannabinoid medicine. The panel debated the implications for patient access.
// Source
Ep. 068 Hash Church LXVIII 68 →